Treating PSMA-positive patients with mHSPC with the radioligand 177Lu-PSMA-617 on top of standard of care reduces their risk for radiographic progression or death. In patients with PSMA-positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback